1 Introduction

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

2 Executive Summary

2.1 CXO perspective

3 Market Overview

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Government regulations
3.4 Porter’s five force analysis
3.5 Top Player Positioning, 2015
3.6 Market dynamics 3.6.1 Drivers

3.6.2 Restraints
3.6.3 Opportunities

4 World Endovascular Abdominal Aortic Aneurysm Repair Devices Market, By Technique

4.1 Infrarenal

4.1.1 Key market trends
4.1.2 Key growth factors and opportunities
4.1.3 Market size and forecast

4.2 Juxtarenal

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

5 World Endovascular Abdominal Aortic Aneurysm Repair Devices Market, By Anatomy Condition

5.1 Traditional anuerysm (Endovascular aortic aneurysms with aortic neck lengths>=10 mm)

5.1.1 Market size and forecast

5.2 Complex anuerysm (Endovascular aortic aneurysms with aortic neck lengths <10mm)

5.2.1 Market size and forecast

6 World Endovascular Abdominal Aortic Aneurysm Repair Devices Market, By Region

6.1 North America

6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast
6.1.4 U.S.
6.1.5 Canada
6.1.6 Mexico

6.2 Europe

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 Germany
6.2.5 France
6.2.6 Italy
6.2.7 Spain
6.2.8 U.K.
6.2.9 Rest of Europe

6.3 Asia Pacific

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 China
6.3.5 Japan
6.3.6 India
6.3.7 South Korea
6.3.8 Australia
6.3.9 Rest of APAC

6.4 LAMEA

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Brazil
6.4.5 Argentina
6.4.6 South Africa
6.4.7 Israel
6.4.8 Rest of LAMEA

7 Company Profiles

7.1 C.R. Bard, Inc.
7.1.1 Overview
7.1.2 Company snapshot
7.1.3 Financial performance
7.1.4 Operating segment overview 7.1.5 Strategic moves and developments

7.2 Cook Medical, Inc.

7.2.1 Overview
7.2.2 Company snapshot
7.2.3 Financial performance
7.2.4 Operating segment overview 7.2.5 Strategic moves and developments

7.3 Endologix, Inc.

7.3.1 Overview
7.3.2 Company snapshot
7.3.3 Financial performance
7.3.4 Operating segment overview
7.3.5 Strategic moves and developments

7.4 Medtronic, plc

7.4.1 Overview
7.4.2 Company snapshot
7.4.3 Financial performance
7.4.4 Operating segment overview 7.4.5 Strategic moves and developments

7.5 W. L. Gore & Associates, Inc.

7.5.1 Overview
7.5.2 Company snapshot
7.5.3 Financial performance
7.5.4 Operating segment overview
7.5.5 Strategic moves and developments

7.6 B. Braun Melsungen AG

7.6.1 Overview
7.6.2 Company snapshot
7.6.3 Financial performance
7.6.4 Operating segment overview
7.6.5 Strategic moves and developments

7.7 MicroPort Scientific Corporation

7.7.1 Overview
7.7.2 Company snapshot
7.7.3 Financial performance
7.7.4 Operating segment overview
7.7.5 Strategic moves and developments
7.7.6 SWOT analysis

7.8 Lifetech Scientific, Inc.

7.8.1 Overview
7.8.2 Company snapshot
7.8.3 Financial performance
7.8.4 Operating segment overview
7.8.5 Strategic moves and developments
7.8.6 SWOT analysis

7.9 Braile Biomédica

7.9.1 Overview
7.9.2 Company snapshot
7.9.3 Financial performance
7.9.4 Operating segment overview 7.9.5 Strategic moves and developments

7.10 LeMaitre Vascular, Inc.

7.10.1 Overview
7.10.2 Company snapshot
7.10.3 Financial performance
7.10.4 Operating segment overview
7.10.5 Strategic moves and developments